MYDECINE INNOVAT.GRP
Noveris Health Sciences Inc., a biotechnology company, engages in the research, development, and commercialization of psilocybin products to treat mental health conditions. The company primarily focuses on treating nicotine addiction and post-traumatic stress disorder. It also develops MYCO-005, MYCO-006, and MYCO-007 for MDMA and psilocybin analogs. The company has a partnership with Applied Pha… Read more
Market Cap & Net Worth: MYDECINE INNOVAT.GRP (0NF0)
MYDECINE INNOVAT.GRP (F:0NF0) has a market capitalization of $196.00K (€190.95K) as of March 18, 2026. Listed on the F stock exchange, this Germany-based company holds position #47481 globally and #7953 in its home market, demonstrating a 24.18% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying MYDECINE INNOVAT.GRP's stock price €0.15 by its total outstanding shares 1235107 (1.24 Million).
MYDECINE INNOVAT.GRP Market Cap History: 2015 to 2026
MYDECINE INNOVAT.GRP's market capitalization history from 2015 to 2026. Data shows change from $42.79 Million to $196.00K (-44.56% CAGR).
MYDECINE INNOVAT.GRP Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how MYDECINE INNOVAT.GRP's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 0NF0 by Market Capitalization
Companies near MYDECINE INNOVAT.GRP in the global market cap rankings as of March 18, 2026.
Key companies related to MYDECINE INNOVAT.GRP by market ranking:
- Willbes & Co. Ltd. (KQ:008600): Ranked #47472 globally with a market cap of $1.74K USD ( ₩2.55 Million KRW).
- KONGSB AUTOM HOLD (BE:K3A): Ranked #47473 globally with a market cap of $1.74K USD ( €1.70K EUR).
- Thanh Nam Group JSC (VN:TNI): Ranked #47482 globally with a market cap of $1.73K USD ( ₫43.93 Million VND).
- Alchemy Investments Acquisition Corp 1 Warrants (NASDAQ:ALCYW): Ranked #47483 globally with a market cap of $1.73K USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #47472 | Willbes & Co. Ltd. | KQ:008600 | $1.74K | ₩263.00 |
| #47473 | KONGSB AUTOM HOLD | BE:K3A | $1.74K | €0.18 |
| #47482 | Thanh Nam Group JSC | VN:TNI | $1.73K | ₫4540.00 |
| #47483 | Alchemy Investments Acquisition Corp 1 Warrants | NASDAQ:ALCYW | $1.73K | $0.18 |
MYDECINE INNOVAT.GRP Historical Marketcap From 2015 to 2026
Between 2015 and today, MYDECINE INNOVAT.GRP's market cap moved from $42.79 Million to $ 196.00K, with a yearly change of -44.56%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €196.00K | +31.57% |
| 2025 | €148.97K | +4600.00% |
| 2024 | €3.17K | -80.77% |
| 2023 | €16.48K | -94.84% |
| 2022 | €319.49K | -94.40% |
| 2021 | €5.71 Million | -71.06% |
| 2020 | €19.71 Million | +349.42% |
| 2019 | €4.39 Million | -94.70% |
| 2018 | €82.72 Million | -87.87% |
| 2017 | €681.77 Million | +241.43% |
| 2016 | €199.68 Million | +366.67% |
| 2015 | €42.79 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of MYDECINE INNOVAT.GRP was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $196.00K USD |
| MoneyControl | $196.00K USD |
| MarketWatch | $196.00K USD |
| marketcap.company | $196.00K USD |
| Reuters | $196.00K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.